Compare Bandhan Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.43
1.99
NAV
₹9.54
₹38.69
Fund Started
10 Nov 2025
25 Jun 2018
Fund Size
₹273.07 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
-
4.37%
3 Year
-
25.91%
5 Year
-
15.56%
Equity
97.46%
97.62%
Cash
2.52%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.65% |
Apollo Hospitals Enterprise Ltd. | 8.97% |
Divi's Laboratories Ltd. | 7.40% |
Max Healthcare Institute Ltd. | 7.14% |
Dr. Reddy's Laboratories Ltd. | 7.12% |
Cipla Ltd. | 6.72% |
JB Chemicals & Pharmaceuticals Ltd. | 4.91% |
Lupin Ltd. | 3.81% |
Mankind Pharma Ltd. | 3.31% |
Ajanta Pharma Ltd. | 3.08% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 Nov 2025
25 Jun 2018
